Treatment with angiotensin II in COVID-19 patients may not be beneficial.

JSON

Rysz S, Jalde FC, Oldner A, Eriksson LI, Lundberg J, Fagerlund MJ

Crit Care 24 (1) 546 [2020-09-04; online 2020-09-04]

Type: Other

PubMed 32887650

DOI 10.1186/s13054-020-03233-6

Crossref 10.1186/s13054-020-03233-6

pii: 10.1186/s13054-020-03233-6
pmc: PMC7472408